Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
-
Lewis, James H. (MedStar Georgetown University Hospital)
;
Gelderblom, Hans J (Leiden University Medical Center) ;
van de Sande, Michiel (Leiden University Medical Center (Països Baixos)) ;
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Healey, John H. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ;
Tap, William D. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ;
Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Druta, Mihaela (Moffitt Cancer Center (Tampa, Florida)) ;
Lin, ChiaChi Chi Josh (National Taiwan University Hospital (Taipei, Taiwan)) ;
Baba, Hideo Andreas (University Hospital Essen (Alemanya)) ;
Choi, Youngsook (Daiichi Sankyo. Inc (Nova Jersey, Estats Units)) ;
Wang, Qiang (Daiichi Sankyo. Inc (Estats Units)) ;
Shuster, Dale E. (Daiichi Sankyo. Inc (Estats Units))) ;
Bauer, Sebastian (University of Duisburg-Essen (Alemanya))
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
